Hyperhomocysteinemia is frequent in patients with coronary disease. Study of 202 cases;La hiperhomocisteinemia es frecuente en pacientes con enfermedad coronaria. Estudio de 202 enfermos

Medicina Clinica

Volumn 113, Issue 11, 1999, Pages 407-410

  Fernández Miranda, Consuelo ^a   Aranda, José Luis ^a   González, Pilar Gómez ^a   Díaz Rubio, Pilar ^a   Estenoz, Juana ^a   Gómez De La Cámara, Agustín ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Coronary disease; Folic acid; Homocysteine; Lipoproteins; Vitamin B12

Indexed keywords

CREATININE; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK;

AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CORONARY DISEASE; CREATININE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO;

EID: 0033539260     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1.114-1.119.
2. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman D et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-881.
3. Ubbink JB, Vermaak WJ, Bennett JM, Becker PJ, Van Staden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991; 69: 527-534.
4. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO et al. Plasma homocysteine, folate and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994; 59: 940-948.
5. Von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schönfeld R et al. Effects of age, lipoproteins and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb 1994; 14: 460-464.
6. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704-709.
7. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1.775-1.781.
8. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease. Results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158: 862-867.
9. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 1994; 25: 1.924-1.930.
10. Vila N, Deulofeu R, Chamorro A, Piera C. Concentraciones plasmáticas de homocisteina en pacientes con infarto cerebral isquémico. Med Clin (Barc) 1998; 110: 605-608.
11. Mansoor MA, Bergmark C, Svardal A, Lonning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995; 15: 232-240.
12. Altthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J et al. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finish population based study. Atherosclerosis 1994; 106: 9-19.
13. Robinson K, Mayer EL, Miller DP, Green R, Van Lente F, Gupta A et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995; 92: 2.825-2.830.
14. Malinow MR, Ducimetiere P, Luc G, Evans AE, Arveiler D, Cambien F et al. Plasma homocysteine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis 1996; 126: 27-34.
15. Shipchandler MT, Moore EE. Rapid, fully automated measurement of plasma homocysteine with the Abbott lmx analyser. Clin Chem 1995; 41: 991-994.
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1.183-1.197.
17. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH. Homocysteine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997; 17: 1.947-1.953.
18. Folsom AR, Nieto J, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The atherosclerosis risk in communities (ARIC) study. Circulation 1998; 98: 204-210.
19. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Arch Intern Med 1992; 152: 56-64.
20. Egerton W, Silberberg J, Crooks R, Ray C, Xie L, Dudman N. Serial measures of plasma homocysteine after acute myocardial infarction. Am J Cardiol 1996; 77: 759-761.
21. Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995; 237: 381-388.
22. Wouters MGAJ, Moorrees EC, Van der Mooren MJ, Blom HJ, Boers GHJ, Schellekens LA et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995; 25: 801-805.
23. Brattström L, Lindgren A, Israelsson B, Anderson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633-641.
24. Dalery K, Lussier-Cacan J, Selhub J, Davignon J, Latour Y, Genest J. Homocysteine and coronary artery disease in french canadian subjects: relation with vitamins B12, B6, piridoxal phosphate and folate. Am J Cardiol 1995; 75: 1.107-1.111.
25. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995; 116: 59-62.
26. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand Clin Lab Invest 1996; 56: 41-46.
27. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
28. Nygard O, Refsum H, Ueland PM, Farstad M, Vollset SE, Nordrehaug JE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 1.632-1.633.
29. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286-291.
30. Donner MG, Klein GK, Mathes PB, Schwandt P, Richter WO. Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile. Metabolism 1998; 47: 273-279.
31. Moghadasian MH, McManus BM, Frohlich JJ. Homocysteine and coronary artery disease. Arch Intern Med 1997; 157: 2.299-2.308.
32. Córdoba Porras A, Blanco Vaca F, Gonzalez Sastre F. Hiperhomocisteinemia, un nuevo marcador de riesgo vascular: territories vasculares afectados, papel en la patogénesis de la arteriosclerosis y la trombosis y tratamiento. Med Clin (Barc) 1997; 109: 715-725.
33. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J 1998; 316: 894-898.
34. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1.049-1.057.
35. Rothkopf MM, Franco A, Usiskin K, Haverstick L, Malone M. Improvement of coronary artery disease in a patient with hyperhomocysteinemia: report of a case. Nutrition 1998; 14: 687-690.